MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer

Nicholas G Nickols, Ramin Nazarian, Shuang G Zhao, Victor Tan, Vladislav Uzunangelov, Zheng Xia, Robert Baertsch, Elad Neeman, Allen C Gao, George V Thomas, Lauren Howard, Amanda M De Hoedt, Josh Stuart, Theodore Goldstein, Kim Chi, Martin E Gleave, Julie N Graff, Tomasz M Beer, Justin M Drake, Christopher P EvansRahul Aggarwal, Adam Foye, Felix Y Feng, Eric J Small, William J Aronson, Stephen J Freedland, Owen N Witte, Jiaoti Huang, Joshi J Alumkal, Robert E Reiter, Matthew B Rettig

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences